
Pfizer Soars With Covid-19 Vaccine Announcement
Pharmaceutical giant Pfizer (PFE) brought welcoming news to global markets, following their announcement that their COVID-19 vaccine trials showed a 90% success rate.
Pharmaceutical giant Pfizer (PFE) brought welcoming news to global markets, following their announcement that their COVID-19 vaccine trials showed a 90% success rate.
US president Donald Trump tweeted that both he and the First Lady had tested positive for COVID-19, causing volatility in various global financial markets. Oil dropped by as much as 5% on Friday.
The first of these new measures, requiring hospitality venues to close doors at 10PM. While British Prime Minister Boris Johnson is planning to address the nation in the coming days with wider restrictions.
This week’s announced shakeup of the Dow Jones Industrial Average may be a sign of a changing economy and changing global demands. Salesforce, Amgen, & Honeywell will take the place of Exxon, Pfizer, & Raytheon.
Videos & Articles help you expand your trading knowledge.
Our Economic calendar helps you explore global market events.
Understand the full costs of your trades now for better expense management later.
This information is written by Ecxmarket Ltd. The information is provided for general purposes only, and does not take into account any personal circumstances or objectives. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, if necessary, seek professional advice. No representation or warranty is given as to the accuracy or completeness of this information. It does not constitute financial, investment or other advice on which you can rely. Any references to past performance, historical returns, future projections, and statistical forecasts are no guarantee of future returns or future performance. Ecxmarket will not be held responsible for any use that may be made of this information and for any consequences that may result from such use. Hence, any person acting based on this information does so at their own discretion. The information has not been prepared in accordance with legal requirements designed to promote the independence of investment research.